Skip to main content

Germany’s HepatoSys Liver Research Network Licenses Genedata Software

NEW YORK (GenomeWeb News) - Genedata has entered into a collaboration with HepatoSys, a consortium of German research centers studying the physiology and pathophysiology of the human liver using systems biology, the company said today.
 
Genedata said that the consortium has licensed its Phylosopher and Expressionist software packages. The company has partnered with the HepatoSys researchers to use the software as the basis for a computational system to analyze molecular processes in mammalian liver cells.
 
The HepatoSys consortium is investigating signaling pathways, gene regulation mechanisms, cell signaling dynamics, and metabolic activity in hepatocytes. It plans to cellular simulation with experimental data analysis to understand the biochemical functions of the liver.
 
Genedata is also developing a customized data-management platform based on its software for the HepatoSys network that will represent dynamic pathway models.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.